Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease

Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease

Alzheimer’s disease (AD) is a polygenic/complex disorder in which genomic, epigenomic, cerebrovascular, metabolic, and environmental factors converge to define a progressive neurodegenerative phenotype. Pharmacogenetics is a major determinant of therapeutic outcome in AD. Different categories of gen...

Full description

Bibliographic Details
Main Authors: Ramón Cacabelos, Arun Meyyazhagan, Juan C. Carril, Pablo Cacabelos, Óscar Teijido
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:Journal of Personalized Medicine
Subjects:
Alzheimer’s disease
anti-dementia drugs
APOE
atorvastatin
cholesterol
CYP haplotypes
Enalapril
hypertension
LipoEsar
pharmacogenetics
Online Access:http://www.mdpi.com/2075-4426/8/1/3

Internet

http://www.mdpi.com/2075-4426/8/1/3

Similar Items